|
|||||
|
|
A preliminary report of a Phase II study of folinic acid, 5-fluorouracil, irinotecan (FOLFIRI) plus sunitinib with toxicity, efficacy, pharmacokinetics, biomarker, imaging data in patients with colorectal cancer with liver metastases as 1st line treatment |
|
| Authors: | Mross K Büchert M Fasol U Jaehde U Kanefendt F Strumberg D Arends J Hense J Moritz B Fischer R Scheulen M E |
| Affiliation: | Tumor Biology Center at the Albert-Ludwigs-University Freiburg,Germany. mross@tumorbio.uni-freiburg.de |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |